title: Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma.
authors.affiliation: University of Arkansas for Medical Sciences, Little Rock, AR lgao@uams.edu.
authors.forename: Mallory B
authors.initials: MB
authors.lastname: Shiver
authors.forename: Fade
authors.initials: F
authors.lastname: Mahmoud
authors.forename: Ling
authors.initials: L
authors.lastname: Gao
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015266:Carcinoma, Merkel Cell / Q000188:drug therapy / Q000235:genetics / Q000556:secondary*; D045744:Cell Line, Tumor; D058534:Class I Phosphatidylinositol 3-Kinases; D005260:Female; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D009367:Neoplasm Staging; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics* / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use*; D052999:Quinazolinones / Q000627:therapeutic use*; D011859:Radiography; D011877:Radionuclide Imaging; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D058534:Class I Phosphatidylinositol 3-Kinases; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D047428:Protein Kinase Inhibitors; D011687:Purines; D052999:Quinazolinones; C484760:PIK3CA protein, human; C552946:idelalisib